Lazy eye drug trial offers new hope for older kids
NCT ID NCT07226141
First seen Nov 10, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study tests whether adding valproate to standard patching therapy can improve vision in children aged 8 to 17 with lazy eye (amblyopia) that hasn't fully resolved. Participants will take valproate or a placebo daily for 16 weeks while patching their good eye for 2 hours a day. The goal is to see if the drug helps the weaker eye see better and possibly achieve normal vision.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMBLYOPIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Boston Children's Waltham
Waltham, Massachusetts, 02453, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.